Search results for drug

“NSAIDS and other drugs Taking nonsteroidal anti-inflammatory drugs (NSAIDS) to prevent hangovers is not advised and could be harmful. These medications slow down the enzymes that metabolize alcohol and its byproducts.”

“The study included nearly 700 cognitively normal adults who were enrolled in the Alzheimer’s Disease Neuroimaging Initiative study. Participants provided information regarding regular (at least once a week for more than six months) use of anticholinergic drugs.”

Dr. Rhonda Patrick explores creatine, dairy's effect on polyphenols, eggs' health impact, and new weight loss drugs like Ozempic in her latest Q&A.

“The degree of protection was dependent upon the timing of drug administration during the course of the disease, with earlier being better. These findings suggest that EIDD-2801 is effective against COVID-19 respiratory symptoms in mice.”

“Multiple studies have investigated the possibility that dietary strategies or drugs can alter nutrient-sensing pathways to improve metabolic health and extend lifespan. For example, robust evidence indicates that intermittent fasting and calorie restriction prolong lifespan in rodents and monkeys.”

“1,000 non-antibiotic drugs were tested against 40 representative gut bacterial strains and found that 24% of the drugs inhibited the growth of at least one bacterial strain in-vitro. These observations agree with the few clinical microbiome studies for which medication has been recorded to affect the gut microbiome.”

“Research from epigenetics expert Steve Horvath is the first to demonstrate the reversal of epigenetic aging and immunosenescence of the thymus with drug therapy. The thymus is an immune organ necessary for the development of T cell populations.”

“Finasteride is one of the most popular prescription drugs for male hair loss, but questions about its psychiatric safety have lingered for over two decades. A new review analyzed postmarketing data to determine whether the drug contributes to depression, anxiety, or suicidality, and to examine why these risks took so long to be recognized.”

“The median time for an FDA action to pose new safety risks or withdraw a drug after the drug already hit the market was 4.2 years after approval. The problem is that many clinical trials used for FDA approval involve fewer than 1,000 participants with follow-up of 6 months or less!”

“The drug, called Vascepa (icosapent ethyl), reduces blood triglyceride levels by one-third when accompanied by low-fat, low-cholesterol dietary modification. It has been shown to reduce the rate of heart attacks, strokes, and other cardiovascular events by 25 percent compared to a placebo.”